RxDoctor Payments Data

Tony de Martini, MD

Interventional Cardiology · Springfield, ILNPI 1174604631

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $150,340 of the $208,459 with a category attached, or 72.1%. Boston Scientific accounts for 64.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $75,583 and has fallen 90.1% since, to $7,446 in 2025. Among interventional cardiology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$208,459in general payments, 2019–2025

Across 257 payments — averaging $811.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$135K
  • Asahi Intecc USA, Inc.$29K
  • Siemens Medical Solutions USA, Inc.$21K
  • Abbott$13K
  • Abiomed$5K
  • Medtronic$3K
  • plus $1K from 6 others

What the payments were for

  • Consulting fees$32,45016%
  • Speaking & faculty fees$150,34072%
  • Travel & lodging$16,6648%
  • Food & beverage$9,0024%
  • Education$20%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific120$135,227
Asahi Intecc USA, Inc.73$29,167
Siemens Medical Solutions USA, Inc.14$21,156
Abbott7$13,350
Abiomed14$5,407
Medtronic(2 entities)18$3,053
Asahi Intecc CO., LTD.2$337
Shockwave Medical, Inc4$261
Verge Medical, Inc.2$167
Edwards Lifesciences1$161
Shimadzu Precision Instruments, Inc.1$150
Novartis1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$208,459 in reported general payments places this provider in the 95th percentile of 303 interventional cardiology providers in Illinois.

See all interventional cardiology providers in Illinois

Medicare billing

Part B allowed, 2024
$16,766
Medicare patients
41
Services billed
75

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban35$29,300
XareltoRivaroxaban13$20,552
Repatha SureclickEvolocumab12$6,447
ClopidogrelClopidogrel Bisulfate79$873
Metoprolol Succinate36$548
Atorvastatin Calcium67$471
Carvedilol45$344
Amlodipine Besylate35$231
Losartan Potassium24$226
Metoprolol Tartrate32$226
Lisinopril19$189
Furosemide20$145
Rosuvastatin Calcium15$94
Isosorbide Mononitrate ErIsosorbide Mononitrate16$92

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Springfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →